Clinical Trial Update: Identifying Immune-related Biomarkers to Predict the Efficacy of Cancer Immunotherapy [NA]

View source ↗

Summary

This clinical trial update reports completion of a study to identify immune-related biomarkers that predict the efficacy of cancer immunotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Non-hodgkin Lymphoma
• Urinary Tract Neoplasms

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Lung Cancer Metastatic, Locally Advanced Malignant Neoplasm | NA | Status: COMPLETED